Clover Health will join the public market by merging with Social Capital SPAC
Clover Health, an insurtech company for Medicare Advantage plans, will become publicly traded through a merger with special purpose acquisition company (SPAC) Social Capital Hedosophia Holdings Corp....
View ArticleSPAC update: Butterfly Network's blank check deal and UpHealth's three-way...
The back half of November saw two special purpose acquisition companies (SPACs) announce merger agreements valued at more than $1 billion.First on the list is Butterfly Network, maker of the Butterfly...
View Article23andMe heads to public markets through SPAC merger with VG Acquisition Corp.
Consumer genomics platform 23andMe is on its way to becoming a publicly-traded company through its merger with VG Acquisition Corp., a special purpose acquisition company sponsored by Virgin Group.The...
View ArticleInfant monitoring tech brand Owlet announces SPAC merger for Q2 2021
Editor's note: This article has been updated with original quotes from the heads of Owlet Baby Care and Sandbridge Acquisition.Owlet Baby Care, the maker of connected infant-monitoring products...
View ArticleClik here to view.
Contributed: Blank check-up uncovers a digital health SPAC attack
The 2020s are on course to become the decade of the special purpose acquisition companies (SPACs), also known as "blank check" or "shell" companies. SPACs are set to outpace IPOs once again in 2021,...
View ArticleSPAC deals attract younger, less-funded digital health startups
Special purpose acquisition companies, or SPACs, have taken the digital health market by storm over the past year and a half. Already in 2021 there have been more completed or announced public exits by...
View ArticleClinical trial platform Science 37 latest digital health startup to enter SPAC
Science 37, a decentralized clinical trial operating system developer, has shared it's going public through a merger with special purpose acquisition company LifeSci Acquisition II Corp.Upon completion...
View ArticlePear Therapeutics raises up to $50M in additional capital ahead of SPAC
Digital prescription therapeutic company Pear Therapeutics announced Monday it had secured up to $50 million in additional capital from an affiliate of Thimble Point Acquisition Corp., the special...
View ArticlePear Therapeutics completes SPAC, begins trading on Nasdaq
Prescription digital therapeutics company Pear Therapeutics began trading on Nasdaq Monday after wrapping up its merger with special-purpose acquisition company Thimble Point Acquisition Corp. last...
View ArticleVideo game therapeutic developer Akili Interactive to go public via SPAC
Akili Interactive, maker of a video game-based digital therapeutic for treating pediatric ADHD, announced Wednesday it plans to go public through a merger with special-purpose acquisition company...
View Article
